UPDATE: Morgan Stanley Starts Talaris Therapeutics (TALS) at Overweight
Tweet Send to a Friend
(Updated - June 1, 2021 4:12 AM EDT)
Morgan Stanley analyst Vikram Purohit initiates coverage on Talaris Therapeutics (NASDAQ ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
Morgan Stanley analyst Vikram Purohit initiates coverage on Talaris Therapeutics (NASDAQ ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
